Submucosal Lipiodol Injection to Guide Radiotherapy for Esophageal Cancer | OMICS International | Abstract
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Submucosal Lipiodol Injection to Guide Radiotherapy for Esophageal Cancer

Han Yao, Christian Boukaram and George Rakovich*

George Rakovich, thoracic surgery, University of montreal, Canada

*Corresponding Author:
George Rakovich
thoracic surgery
University of montreal, Canada
Tel: 1-514-252-3400
E-mail: [email protected]

Received date: July 30, 2014; Accepted date: October 17, 2014; Published date: October 24, 2014

Citation: Yao H, Boukaram C, Rakovich G (2014) Submucosal Lipiodol Injection to Guide Radiotherapy for Esophageal Cancer. J Gastroint Dig Syst 4:230. doi:10.4172/2161-069X.1000230

Copyright: © 2014 Yao H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Radiotherapy for esophageal cancer relies on cross-sectional imaging to identify the entire extent of tumor. Rarely, the exact limits of the tumor may be radiologically occult. Lipiodol is a contrast agent which has been used successfully to mark cancers of the bladder and lung for radiotherapy and surgical resection. We report a patient with an adenocarcinoma of the gastroesophageal junction with tiny tumor implants extending proximally along the length of the esophagus, which were not visible on standard cross-sectional imaging studies. The proximal extent of implants was marked endoscopically using a submucosal injection of lipiodol, and this provided for adequate planning and successful delivery of radiotherapy.